Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.
Source: [CNBC](https://www.cnbc.com/2026/07/22/axiom-aiosciences-ipo-listing-hong-kong.html)
📰 Read Full Story
This is an aggregated headline summary. For the complete report, visit the original publisher.
Continue Reading at CNBC ↗